Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
It wouldn't surprise me if they add it as a function to the test and trace app because that is also due soon. Self reporting isn't ideal and some people just won't do it. But most people who know they're infected will at least self isolate. I think govt will take the risk and put some of the responsibility on the public like they have with masks and social distancing in general. If the test works as advertised govt will buy as many as they can make initially then once production is ramped to a certain level the tests will be sold direct to the consumer through Medusa 19. There will almost certainly be a new manufacturing partner or 2 in the coming weeks (if it works), then the sky's the limit. Any vaccine won't make a dent in testing needs for at least a year but by then we'll hopefully have tons of cash in the bank and a successful cancer therapy. It's all good people, chill.
I've topped up with 10k new shares on the US govt buying up all Abbott's tests. The market is massive and even with competitors eating some of the market share Avacta still stands to benefit hugely (if the test works and they don't delay too much).
UK government policy is to test 4 million people a day by the NY. PCR testing currently accounts for approx 150k tests a day and require a massive organised operation including healthcare professionals and labs. Its reasonable to assume they couldn't scale up to more than a million tests a day for PCR. That leaves 3 million tests a day which will likely be completed using LFT anti gen tests. Even assuming that other LFT anti gen test providers take up 2 of that remaining 3 million a day, that leaves Avacta providing 1 million tests a day. BBI have said that they will be able to produce 'millions' of a tests a month at the start, which suggests capacity of less than 10 million a month to begin with, but if the test works then additional manufacturers will be found to scale up by NY. All in all it's reasonable to assume that UK govt alone will be buying 30 million tests a month from Avacta come the NY. Avacta quoted a retail price of $30 a few months back, but even assuming a lower price it's also reasonable to assume a profit per unit of $2-4. That's $60 million profit a month and $720 million profit a year. And these are low estimates, because if the test works as advertised and they can get additional manufacturers on board to produce say, 100 million tests a month, they will all sell and it will make them a $200 million a month and $2.4 billion over 12 months. I think on announcement the test works as advertised we will see a rise to £3. On news of orders it will hit £4 or £5. On news of a large scale up in manufacturing and pre-orders it will head up towards £10. If the cancer therapies work next year then we're looking at a SP above £10. After that the sky's the limit.
Bang on Phantom. AW, you know as well as I we do a company doesn't have to make profit equal to the value of its MCAP to justify that MCAP. Prime example at the moment - Tesla.
Looks like Palumbo has come through for us! This should be the catalyst for more contracts signed, more projects in the pipeline and a serious re rate! Slightly gutted I sold a 1/4 of my goldings last week when no news came for Greece but hey, you can't win them all.
This is an encouraging Tweet.
https://twitter.com/eqtec/status/1298249814396694529?s=19
Well, unless we get an intra day RNS it would appear they haven't taken the option to buy out Scott Bros SPV for Billingham. IMO that makes Billingham less likely to happen. I'll see what today brings before I jump the gun.
No need to panic. Investors reacting to the lack of news, Trump's 'new' treatment and the rumour the FDA will fastrack a vaccine which they think will render these tests not needed. Fact remains that our own government has a strong desire to see rapid testing and unless it doesn't work or there are big delays in manufacturing there will be massive demand from the UK govt alone. Hold your nerve.
Been watching this share for a while but have jumped on board this morning (albeit at the peak). Should see significant moves up over the coming months so not worried about my entry price. Todays new significantly derisks the share.
I have to admit if nothing has come by Tuesday (the deadline for purchasing the SPV owned by Scott Bros), I will be re-evaluating my holdings. Going on DP's comments and the previous RNS's deadlines, something should have been announced by Tuesday and if it isn't I don't think it bodes well.
The MOU for Billingham is actually until 22nd Sept. What you're likely referring to is the option for Eqtec to buy out the SVP from Scott Bros which was stated to be 45 days from when they announced it, which is up on 24th Aug. If that date lapses with no news then it doesn't mean Billingham won't go ahead, it just means they haven't bought our Scott Bros share. But if they announce the buyout of the SPV on or before 24th Aug then it's a sure sign Billingham will almost certainly go ahead. Time will tell.
I agree, Greek project keeps getting touted as being on the brink of being closed but it never is. In his interview 14 days ago he said 'a couple of weeks'. He also said 'a couple of weeks' at the end of May. I've de-risked a bit as a result. I'm still confident news will come, but I needed some cash to invest in another promising company with potential to multi-bag soon!
People are slightly nervous about the Aries case (understandable), so without confirmation of financial close on Greece, Billingham (or anything really!), I can't see the SP moving up any more.
DP said Greece would financially close in June and the company has an unfortunate record of not closing out on MOU's and JV's. If he can close Greece before the end of August (or provide a good reason why he hasn't) then I'll hold my 10 million shares and I think we'll see a move up towards 1p. If that time passes and nothing has been closed I'll sell half my stake in anticipation of Billingham being financially closed by the 22nd Sept MOU extension deadline. If the MOU is extended again without a very good reason I'll likely sell my entire stake and I think at that point the SP would drift back down towards 0.4 or even 0.3.
If Greece and Billingham are financially closed it will create a snowball effect and EQTEC will be able to fund the likes of Deeside, the Ireland projects, the Balkans and likely many more, which will see the SP head to 2p and above. At this point the court case becomes pretty immaterial because win or lose they have the funds to pay the lawyers and they have a big foothold in Europe where they will make most of their revenue anyway.
The fund raise was necessary -albeit annoying, but DP said himself the money is to speed up the closing out of near term projects. If he cannot do this now he will never be able to do it.
As for the easy-Stelios speculation, it's just that - speculation. Maybe, maybe not. If it happens - awesome! If it doesn't, DP needs to deliver on the above and more without the financial muscle an investment like that would bring.
Talk of 5p plus by the end of the year is fanciful unless DP closes multiple big contracts (and/or a large waste EPC or waste infrastructure owner/operator comes in and takes a strategic interest in the compan.)
My average is 0.54, so fingers crossed from here that DP can deliver.